{
    "Trade/Device Name(s)": [
        "MissLan\u2122 Digital Pregnancy Rapid Test"
    ],
    "Submitter Information": "Guangzhou Decheng Biotechnology Co., Ltd.",
    "510(k) Number": "K222305",
    "Predicate Device Reference 510(k) Number(s)": [
        "K173229"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "November 30, 2022",
    "Summary Letter Received Date": "August 2, 2022",
    "Submission Date": "July 31, 2022",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin (hCG) Test System"
    ],
    "Analyte Class(es)": [
        "endocrine"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (hCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow immunoassay",
        "Light reflection detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Rapid Test"
    ],
    "Document Summary": "FDA 510(k) summary for MissLan\u2122 Digital Pregnancy Rapid Test for qualitative detection of hCG in urine using immunochromatographic and lateral flow technology.",
    "Indications for Use Summary": "Intended for qualitative detection of human chorionic gonadotropin (hCG) in urine as an aid in early detection of pregnancy, for over-the-counter home use.",
    "fda_folder": "Clinical Chemistry"
}